Get the tools used by (smart)2 investors.

Price / Book for Eli Lilly and Company

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

LLY: Eli Lilly and Company

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, H...

818.22 USD
Price
USD
Fair Value
Upside
711.40 - 972.53
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Eli Lilly and Company's Price / Book:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.0x20.0x40.0x60.0x

Performance Summary
  • Eli Lilly's latest twelve months price / book is 51.8x
  • Eli Lilly's price / book for fiscal years ending December 2020 to 2024 averaged 39.4x.
  • Eli Lilly's operated at median price / book of 34.5x from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Eli Lilly's price / book peaked in December 2024 at 51.8x.
  • Eli Lilly's price / book hit its 5-year low in December 2020 of 31.7x.
  • Eli Lilly's price / book decreased in 2020 (31.7x, -15.0%) and increased in 2021 (32.3x, +1.8%), 2022 (34.5x, +6.9%), 2023 (46.7x, +35.3%), and 2024 (51.8x, +10.8%).

How does Eli Lilly's Price / Book benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Eli Lilly and Company because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Price / Book

Hide this widget
price_to_book
Slug
number
Datatype
text
Format
current
Default Period
FY, LTM
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Price / Book in the valuation category include:

View Full List

Search for metric or datapoint

Price / Book

Compares a firm's market value of equity to the amount of common equity listed on the balance sheet.

Definition of Price / Book

Hide this widget

Price to Book is defined as:

Price / Book = Market Cap / Common Equity

Applying this formula, Eli Lilly’s Price / Book is calculated below:

Market Capitalization [ $734.8 B ]
(/) Common Equity [ $14.192 B ]
(=) Price / Book [ 51.8x ]

Price / Book (P/B) also known as the price-to-book ratio, or P/B ratio, is a financial ratio that compares a company’s current market cap to its book value. It is the inverse of Book to Market and the same as Market Cap / Book Value.

The tables below summarizes the trend in Eli Lilly’s price / book over the last five years:

Date Market Cap Book Value Price / Book
2020-12-31 178.9 B 5.642 B 31.7
2021-12-31 289.9 B 8.979 B 32.3
2022-12-31 367.6 B 10.65 B 34.5
2023-12-31 503.3 B 10.772 B 46.7
2024-12-31 734.8 B 14.192 B 51.8

Click the link below to download a spreadsheet with an example Price / Book calculation for Eli Lilly and Company below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-6.3x-1.3x3.7x13.2x050100150

The chart above depicts the distribution of price / book for companies operating in the Healthcare sector in the Developed economic region. Over 3,175 companies were considered in this analysis, and 2,217 had meaningful values. The average price / book of companies in the sector is 3.2x with a standard deviation of 3.1x.

Eli Lilly and Company's Price / Book of 51.8x is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

Price / Book In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents3,180
Included Constituents2,217
Min-5.8x
Max12.7x
Median2.7x
Mean3.2x
Standard Deviation3.1x

You can find companies with similar price / book using this stock screener.

All rights reserved. Terms Of Use